Intimate Relationship Between Stress and Human Alpha‑Herpes Virus 1 (HSV‑1) Reactivation from Latency
Overview
Authors
Affiliations
Purpose Of Review: Numerous studies concluded stress (acute, episodic acute, or chronic) increases the incidence of human alpha-herpes virus 1 (HSV-1) reactivation from latency in neurons. This review will summarize how stress stimulates viral gene expression, replication, and reactivation from latency.
Recent Findings: Stress (capital S) stress-mediated activation of the glucocorticoid receptor (GR) accelerates reactivation from latency, whereas a corticosteroid-specific antagonist impairs viral replication and reactivation from latency. GR and specific stress-induced cellular transcription factors also stimulate viral promoters that drive expression of key viral transcriptional regulators: infected cell protein 0 (ICP0), ICP4, ICP27 and viral tegument protein (VP16). Hence, GR is predicted to initially stimulate viral gene expression. GR-mediated immune-inhibitory functions are also predicted to enhance viral replication and viral spread.
Summary: Identifying cellular factors and viral regulatory proteins that trigger reactivation from latency in neurons may provide new therapeutic strategies designed to reduce the incidence of reactivation from latency.
Hypoxic reactivation of Kaposi's sarcoma associated herpesvirus.
Singh R, Torne A, Robertson E Cell Insight. 2024; 3(6):100200.
PMID: 39391006 PMC: 11466537. DOI: 10.1016/j.cellin.2024.100200.
A review of HSV pathogenesis, vaccine development, and advanced applications.
Bai L, Xu J, Zeng L, Zhang L, Zhou F Mol Biomed. 2024; 5(1):35.
PMID: 39207577 PMC: 11362470. DOI: 10.1186/s43556-024-00199-7.
The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis.
Antony F, Kinha D, Nowinska A, Rouse B, Suryawanshi A Clin Microbiol Rev. 2024; 37(3):e0000624.
PMID: 39078136 PMC: 11391706. DOI: 10.1128/cmr.00006-24.
El-Mayet F, Santos V, Wijesekera N, Lubbers S, Harrison K, Sadeghi H Antiviral Res. 2024; 225:105870.
PMID: 38556059 PMC: 11109923. DOI: 10.1016/j.antiviral.2024.105870.
Harrison K, Wijesekera N, Robinson A, Santos V, Oakley R, Cidlowski J J Virol. 2023; 97(10):e0130523.
PMID: 37823644 PMC: 10617412. DOI: 10.1128/jvi.01305-23.